share_log

Shenzhen Infinova (SZSE:002528) Adds CN¥372m to Market Cap in the Past 7 Days, Though Investors From a Year Ago Are Still Down 73%

Shenzhen Infinova (SZSE:002528) Adds CN¥372m to Market Cap in the Past 7 Days, Though Investors From a Year Ago Are Still Down 73%

深圳英飛拓(SZSE:002528)在過去7天內增加了人民幣37200萬元的市值,儘管一年前的投資者仍然虧損了73%
Simply Wall St ·  09/09 18:55

This week we saw the Shenzhen Infinova Limited (SZSE:002528) share price climb by 14%. But that is meagre solace when you consider how the price has plummeted over the last year. Indeed, the share price is down a whopping 73% in the last year. Arguably, the recent bounce is to be expected after such a bad drop. Only time will tell if the company can sustain the turnaround.

本週我們看到深圳英飛諾華有限公司(深圳證券交易所:002528)的股價上漲了14%。但是,考慮到去年價格的暴跌情況,這只是微不足道的慰藉。事實上,去年股價下跌了73%。可以說,在經歷瞭如此嚴重的跌幅之後,最近的反彈是可以預料的。只有時間才能證明公司能否維持轉機。

Although the past week has been more reassuring for shareholders, they're still in the red over the last year, so let's see if the underlying business has been responsible for the decline.

儘管過去一週令股東更加放心,但與去年相比,他們仍處於虧損狀態,所以讓我們看看基礎業務是否是造成下降的原因。

Shenzhen Infinova wasn't profitable in the last twelve months, it is unlikely we'll see a strong correlation between its share price and its earnings per share (EPS). Arguably revenue is our next best option. When a company doesn't make profits, we'd generally hope to see good revenue growth. That's because it's hard to be confident a company will be sustainable if revenue growth is negligible, and it never makes a profit.

深圳英飛諾華在過去十二個月中沒有盈利,我們不太可能看到其股價與每股收益(EPS)之間存在很強的相關性。可以說,收入是我們的下一個最佳選擇。當一家公司沒有盈利時,我們通常希望看到良好的收入增長。那是因爲如果收入增長可以忽略不計,而且從來沒有盈利,就很難確信一家公司能否實現可持續發展。

Shenzhen Infinova's revenue didn't grow at all in the last year. In fact, it fell 25%. That's not what investors generally want to see. The share price fall of 73% in a year tells the story. Holders should not lose the lesson: loss making companies should grow revenue. But markets do over-react, so there opportunity for investors who are willing to take the time to dig deeper and understand the business.

去年,深圳英飛諾華的收入根本沒有增長。實際上,它下跌了25%。這不是投資者普遍希望看到的。一年內股價下跌73%說明了這一點。持有人不應忘記教訓:虧損公司應該增加收入。但是市場確實反應過度,因此願意花時間深入挖掘和了解業務的投資者有機會。

The graphic below depicts how earnings and revenue have changed over time (unveil the exact values by clicking on the image).

下圖描述了收入和收入隨時間推移而發生的變化(點擊圖片即可顯示確切的數值)。

big
SZSE:002528 Earnings and Revenue Growth September 9th 2024
SZSE: 002528 收益和收入增長 2024 年 9 月 9 日

It's probably worth noting that the CEO is paid less than the median at similar sized companies. It's always worth keeping an eye on CEO pay, but a more important question is whether the company will grow earnings throughout the years. This free interactive report on Shenzhen Infinova's earnings, revenue and cash flow is a great place to start, if you want to investigate the stock further.

可能值得注意的是,首席執行官的薪水低於類似規模公司的中位數。始終值得關注首席執行官的薪酬,但更重要的問題是公司多年來是否會增加收益。如果你想進一步調查深圳英飛諾華的收益、收入和現金流,這份關於深圳英飛諾華收益、收入和現金流的免費互動報告是一個很好的起點。

A Different Perspective

不同的視角

While the broader market lost about 18% in the twelve months, Shenzhen Infinova shareholders did even worse, losing 73%. Having said that, it's inevitable that some stocks will be oversold in a falling market. The key is to keep your eyes on the fundamental developments. Regrettably, last year's performance caps off a bad run, with the shareholders facing a total loss of 8% per year over five years. Generally speaking long term share price weakness can be a bad sign, though contrarian investors might want to research the stock in hope of a turnaround. While it is well worth considering the different impacts that market conditions can have on the share price, there are other factors that are even more important. To that end, you should learn about the 2 warning signs we've spotted with Shenzhen Infinova (including 1 which makes us a bit uncomfortable) .

儘管整個市場在十二個月中下跌了約18%,但深圳英飛諾華股東的表現甚至更糟,跌幅爲73%。話雖如此,在下跌的市場中,一些股票不可避免地會被超賣。關鍵是要密切關注基本發展。遺憾的是,去年的業績結束了糟糕的表現,股東在五年內每年面臨8%的總虧損。總的來說,長期股價疲軟可能是一個壞兆頭,儘管逆勢投資者可能希望研究該股以期出現轉機。儘管市場狀況可能對股價產生的不同影響值得考慮,但還有其他因素更爲重要。爲此,你應該了解我們在深圳英飛諾華發現的兩個警告信號(其中一個讓我們有點不舒服)。

We will like Shenzhen Infinova better if we see some big insider buys. While we wait, check out this free list of undervalued stocks (mostly small caps) with considerable, recent, insider buying.

如果我們看到一些重大的內幕收購,我們會更喜歡深圳英飛諾華。在我們等待的同時,請查看這份被低估的股票(主要是小盤股)的免費清單,這些股票最近有大量的內幕買盤。

Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on Chinese exchanges.

請注意,本文引用的市場回報反映了目前在中國交易所交易的股票的市場加權平均回報。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

對這篇文章有反饋嗎?對內容感到擔憂嗎?請直接聯繫我們。或者,也可以發送電子郵件至編輯團隊 (at) simplywallst.com。
Simply Wall St的這篇文章本質上是籠統的。我們僅使用公正的方法根據歷史數據和分析師的預測提供評論,我們的文章無意作爲財務建議。它不構成買入或賣出任何股票的建議,也沒有考慮到您的目標或財務狀況。我們的目標是爲您提供由基本數據驅動的長期重點分析。請注意,我們的分析可能不考慮最新的價格敏感型公司公告或定性材料。簡而言之,華爾街沒有持有任何上述股票的頭寸。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論